190 related articles for article (PubMed ID: 17177680)
1. Surfactant protein D regulates chemotaxis and degranulation of human eosinophils.
von Bredow C; Hartl D; Schmid K; Schabaz F; Brack E; Reinhardt D; Griese M
Clin Exp Allergy; 2006 Dec; 36(12):1566-74. PubMed ID: 17177680
[TBL] [Abstract][Full Text] [Related]
2. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
3. Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
Mahajan L; Madan T; Kamal N; Singh VK; Sim RB; Telang SD; Ramchand CN; Waters P; Kishore U; Sarma PU
Int Immunol; 2008 Aug; 20(8):993-1007. PubMed ID: 18628238
[TBL] [Abstract][Full Text] [Related]
4. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
5. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx.
Vieira-de-Abreu A; Amendoeira FC; Gomes GS; Zanon C; Chedier LM; Figueiredo MR; Kaplan MA; Frutuoso VS; Castro-Faria-Neto HC; Weller PF; Bandeira-Melo C; Bozza PT
Int Immunopharmacol; 2005 Dec; 5(13-14):1966-74. PubMed ID: 16275631
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils.
Ito W; Chiba T; Kanehiro A; Kato H; Yamaguchi K; Ueki S; Kayaba H; Chihara J
Allergy; 2007 Apr; 62(4):415-22. PubMed ID: 17362253
[TBL] [Abstract][Full Text] [Related]
7. Increased surfactant protein a and d expression in acute ovalbumin-induced allergic airway inflammation in brown norway rats.
Schmiedl A; Lührmann A; Pabst R; Koslowski R
Int Arch Allergy Immunol; 2009; 148(2):118-26. PubMed ID: 18802356
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic surfactants modulate the viability of eosinophils and induce inflammatory mediator release.
Erpenbeck VJ; Fischer I; Wiese K; Schaumann F; Schmiedl A; Nassenstein C; Krug N; Hohlfeld JM
Int Arch Allergy Immunol; 2009; 149(4):333-42. PubMed ID: 19295237
[TBL] [Abstract][Full Text] [Related]
9. Serum surfactant protein D is elevated in allergic patients.
Koopmans JG; van der Zee JS; Krop EJ; Lopuhaä CE; Jansen HM; Batenburg JJ
Clin Exp Allergy; 2004 Dec; 34(12):1827-33. PubMed ID: 15663555
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
11. The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms.
Jäkel A; Clark H; Reid KB; Sim RB
Immunobiology; 2010 Jul; 215(7):551-8. PubMed ID: 19880212
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein A exhibits inhibitory effect on eosinophils IL-8 production.
Cheng G; Ueda T; Nakajima H; Nakajima A; Arima M; Kinjyo S; Fukuda T
Biochem Biophys Res Commun; 2000 Apr; 270(3):831-5. PubMed ID: 10772911
[TBL] [Abstract][Full Text] [Related]
13. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation.
Lamkhioued B; Gounni AS; Gruart V; Pierce A; Capron A; Capron M
Eur J Immunol; 1995 Jan; 25(1):117-25. PubMed ID: 7843220
[TBL] [Abstract][Full Text] [Related]
14. Surfactant protein D in human lung diseases.
Hartl D; Griese M
Eur J Clin Invest; 2006 Jun; 36(6):423-35. PubMed ID: 16684127
[TBL] [Abstract][Full Text] [Related]
15. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.
Kobayashi M; Takeuchi T; Ohtsuki Y
Pathol Int; 2008 Mar; 58(3):203-7. PubMed ID: 18251786
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
Raap U; Goltz C; Deneka N; Bruder M; Renz H; Kapp A; Wedi B
J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146
[TBL] [Abstract][Full Text] [Related]
17. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide.
Ohya M; Nishitani C; Sano H; Yamada C; Mitsuzawa H; Shimizu T; Saito T; Smith K; Crouch E; Kuroki Y
Biochemistry; 2006 Jul; 45(28):8657-64. PubMed ID: 16834340
[TBL] [Abstract][Full Text] [Related]
18. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils.
Costa GG; Silva RM; Franco-Penteado CF; Antunes E; Ferreira HH
Eur J Pharmacol; 2007 Jul; 566(1-3):200-5. PubMed ID: 17368616
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma.
Erpenbeck VJ; Schmidt R; Günther A; Krug N; Hohlfeld JM
Allergy; 2006 May; 61(5):598-604. PubMed ID: 16629790
[TBL] [Abstract][Full Text] [Related]
20. The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functions.
Saito Y; Takeda M; Nishikawa J; Konno Y; Tamaki M; Itoga M; Kobayashi Y; Moritoki Y; Ito W; Chihara J; Ueki S
Pulm Pharmacol Ther; 2014 Apr; 27(2):164-9. PubMed ID: 24333185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
